SOLUTIONS AND METHODS FOR INHIBITING PAIN, CARTILAGE INFLAMMATION AND DESTRUCTION Russian patent published in 2006 - IPC A61K38/08 A61K38/27 A61K38/30 A61K38/55 A61K45/06 A61P19/02 

Abstract RU 2271825 C2

FIELD: medicine.

SUBSTANCE: method involves introducing solutions into articulation to inhibit cartilage destruction. The solutions contain: (a) therapeutically effective amount of anabolic chondroprotective agent selected from a group composed of interleukine antagonists stimulating anabolic processes in cartilage, members of superfamily transforming growth β-factor including TGF-β agonists and agonists of morphogenous bone proteins stimulating anabolic processes in cartilage, insulin-like fibroblast growth factors stimulating anabolic processes in cartilage; (b) therapeutically effective amount of a cartilage catabolism inhibitor selected from a group composed of antagonists of interleukine-1-receptors, antagonists of TGF-α-receptors, specific cyclo-oxygenase-2 inhibitors, nitrogen oxide synthase inhibitors, nuclear kB factor inhibitors, matrix metalloproteinase inhibitors, cell adhesion molecules including integrin agonists and integrin antagonists, anti-chemotaxis agents, intracellular signal transmission inhibitors including protein kinase C inhibitors and tyrosine protein kinase inhibitors, intracellular (protein-tyrosine)-phosphatases and SH2-domain inhibitors inhibiting cartilage catabolism. The solution is locally supplied.

EFFECT: stimulated integration and modulation of anti-inflammatory synoviocyte and chondrocyte responses.

54 cl, 9 dwg, 30 tbl

Similar patents RU2271825C2

Title Year Author Number
METHOD FOR APPLYING ANNEALED PYRROLE COMPOUNDS WHEN TREATING ARTICULAR CARTILAGE DEGENERATION OR STRUCTURAL SUBCHONDRAL BONE TRANSFORMATIONS 2002
  • Pellet'E Zhan-P'Er
  • Martel'-Pellet'E Zhoann
RU2303447C2
DIET COMPOSITION IN CASE OF OSTEOARTHRITIS IN DOGS 2005
  • Uoldron Mark K.
  • Khanna Stiven S.
RU2351153C2
COMPOSITION FOR TREATING ARTHRITIS 2009
  • Fussa Arno
  • Brjun Valeri
  • Asnali Ehlen
  • Bel'Mont Natali
  • Jorgensen Kristian
RU2563360C2
USE OF ARSENIC COMPOUNDS TO TREAT TISSUE OR ORGAN REJECTION 2013
  • Khvang Majkl
  • Yan Yun-Tszin
RU2665362C2
USE OF ARSENIC COMPOUNDS FOR PAIN MANAGEMENT AND INFLAMMATION TREATMENT 2008
  • Khvang Majkl
  • Yan Yun-Tszin
RU2630574C2
PHARMACEUTICAL COMPOSITION, CONTAINING ANTAGONIST OF P2X-RECEPTOR AND NONSTEROID ANTIINFLAMMATORY MEDICAL PRODUCT 2004
  • Bafton-Smit Najdzhel
  • Kruvis Sajmon
RU2338556C2
INHIBITORY SOLUTION AND METHOD OF SUPPRESSION OF PAIN, INFLAMMATION OR SPASM 1995
  • Demopulos Gregori A.
  • Pirs Pamela Ehnn
  • Kherts Dzheffri M.
RU2180852C2
APPLICATION OF PAK INHIBITOR FOR ARTHROPATHY TREATMENT 2004
  • Barrado Sebast'Jan
  • Bartnik Ehkkart
  • Chekh Jorg
  • Klatt Andreas R.
  • Leberer Ehkkekhard
  • Leojv Tomas
RU2360696C2
PROSTAGLANDIN/CYCLOOXYGENASE PATHWAY MODULATION 2007
  • Vjul'Fert Ehrnst
RU2448712C2
PROTEINS BINDING PROSTAGLANDIN E2 AND USING THEM 2009
  • Gu Tszitsze
  • Khatchins Charl'Z V.
  • Chzhu Zhun-Zhun
  • Shehn' Tszjan'Vehj
  • Kharris Marija S.
  • Bilendzher Ehjlin
  • Murtaza Anvar
  • Tarksa Ehdit
  • Stajn Ull'Jam B.
  • Khsiekh Chung-Ming
RU2559525C2

RU 2 271 825 C2

Authors

Demopulos Gregori A.

Palmer Pamela P.

Kherts Dzheffri M.

Dates

2006-03-20Published

2000-07-21Filed